Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses

Immunity

Volumn 27, Issue 1, 2007, Pages 111-122

  Butte, Manish J ^a,b   Keir, Mary E ^a   Phamduy, Theresa B ^a   Sharpe, Arlene H ^a   Freeman, Gordon J ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

MOLIMMUNO; SIGNALING

Indexed keywords

B7 ANTIGEN; BINDING PROTEIN; CD28 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LIGAND; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD80; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOKINES; DOWN-REGULATION; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDES; PROTEIN BINDING; T-LYMPHOCYTES;

EID: 34447646310     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2007.05.016     Document Type: Article

References (53)

1. Baban B., Hansen A.M., Chandler P.R., Manlapat A., Bingaman A., Kahler D.J., Munn D.H., and Mellor A.L. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. Int. Immunol. 17 (2005) 909-919
2. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., and Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 (2006) 682-687
3. Bazzoni G. The JAM family of junctional adhesion molecules. Curr. Opin. Cell Biol. 15 (2003) 525-530
4. + T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile. J. Immunol. 165 (2000) 6908-6914
5. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4 (2004) 336-347
6. Chikuma S., and Bluestone J.A. CTLA-4 and tolerance: the biochemical point of view. Immunol. Res. 28 (2003) 241-253
7. Clauser K.R., Baker P., and Burlingame A.L. Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Anal. Chem. 71 (1999) 2871-2882
8. Collins A.V., Brodie D.W., Gilbert R.J., Iaboni A., Manso-Sancho R., Walse B., Stuart D.I., van der Merwe P.A., and Davis S.J. The interaction properties of costimulatory molecules revisited. Immunity 17 (2002) 201-210
9. Davis S.J., Ikemizu S., Collins A.V., Fennelly J.A., Harlos K., Jones E.Y., and Stuart D.I. Crystallization and functional analysis of a soluble deglycosylated form of the human costimulatory molecule B7-1. Acta Crystallogr. D Biol. Crystallogr. 57 (2001) 605-608
10. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., Mackey E.W., Miller J.D., Leslie A.J., DePierres C., et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443 (2006) 350-354
11. Dong H., and Chen X. Immunoregulatory role of B7-H1 in chronicity of inflammatory responses. Cell Mol. Immunol. 3 (2006) 179-187
12. Dong H., Zhu G., Tamada K., and Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5 (1999) 1365-1369
13. Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., Roche P.C., Lu J., Zhu G., Tamada K., et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8 (2002) 793-800
14. Freeman G.J., Freedman A.S., Segil J.M., Lee G., Whitman J.F., and Nadler L.M. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143 (1989) 2714-2722
15. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C., et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192 (2000) 1027-1034
16. Freeman G.J., Wherry E.J., Ahmed R., and Sharpe A.H. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 203 (2006) 2223-2227
17. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu. Rev. Immunol. 23 (2005) 515-548
18. Grohmann U., Orabona C., Fallarino F., Vacca C., Calcinaro F., Falorni A., Candeloro P., Belladonna M.L., Bianchi R., Fioretti M.C., and Puccetti P. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3 (2002) 1097-1101
19. Ikemizu S., Gilbert R.J., Fennelly J.A., Collins A.V., Harlos K., Jones E.Y., Stuart D.I., and Davis S.J. Structure and dimerization of a soluble form of B7-1. Immunity 12 (2000) 51-60
20. Ito T., Ueno T., Clarkson M.R., Yuan X., Jurewicz M.M., Yagita H., Azuma M., Sharpe A.H., Auchincloss Jr. H., Sayegh M.H., and Najafian N. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. J. Immunol. 174 (2005) 6648-6656
21. Kanai T., Totsuka T., Uraushihara K., Makita S., Nakamura T., Koganei K., Fukushima T., Akiba H., Yagita H., Okumura K., et al. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 171 (2003) 4156-4163
22. Keir M.E., Liang S.C., Guleria I., Latchman Y.E., Qipo A., Albacker L.A., Koulmanda M., Freeman G.J., Sayegh M.H., and Sharpe A.H. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203 (2006) 883-895
23. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R., et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2 (2001) 261-268
24. Latchman Y.E., Liang S.C., Wu Y., Chernova T., Sobel R.A., Klemm M., Kuchroo V.K., Freeman G.J., and Sharpe A.H. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. USA 101 (2004) 10691-10696
25. Liu X., Gao J.X., Wen J., Yin L., Li O., Zuo T., Gajewski T.F., Fu Y.X., Zheng P., and Liu Y. B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J. Exp. Med. 197 (2003) 1721-1730
26. Mandelbrot D.A., McAdam A.J., and Sharpe A.H. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J. Exp. Med. 189 (1999) 435-440
27. Mandelbrot D.A., Oosterwegel M.A., Shimizu K., Yamada A., Freeman G.J., Mitchell R.N., Sayegh M.H., and Sharpe A.H. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4. J. Clin. Invest. 107 (2001) 881-887
28. Matsumoto K., Inoue H., Nakano T., Tsuda M., Yoshiura Y., Fukuyama S., Tsushima F., Hoshino T., Aizawa H., Akiba H., et al. B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism. J. Immunol. 172 (2004) 2530-2541
29. Mellor A.L., Chandler P., Baban B., Hansen A.M., Marshall B., Pihkala J., Waldmann H., Cobbold S., Adams E., and Munn D.H. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. Int. Immunol. 16 (2004) 1391-1401
30. + T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172 (2004) 4100-4110
31. Nabavi N., Freeman G.J., Gault A., Godfrey D., Nadler L.M., and Glimcher L.H. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360 (1992) 266-268
32. Okazaki T., Iwai Y., and Honjo T. New regulatory co-receptors: inducible co-stimulator and PD-1. Curr. Opin. Immunol. 14 (2002) 779-782
33. Orabona C., Grohmann U., Belladonna M.L., Fallarino F., Vacca C., Bianchi R., Bozza S., Volpi C., Salomon B.L., Fioretti M.C., et al. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat. Immunol. 5 (2004) 1134-1142
34. Paust S., Lu L., McCarty N., and Cantor H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. USA 101 (2004) 10398-10403
35. Radhakrishnan S., Iijima K., Kobayashi T., Kita H., and Pease L.R. Dendritic cells activated by cross-linking B7-DC (PD-L2) block inflammatory airway disease. J. Allergy Clin. Immunol. 116 (2005) 668-674
36. Razi-Wolf Z., Freeman G.J., Galvin F., Benacerraf B., Nadler L., and Reiser H. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. USA 89 (1992) 4210-4214
37. Reiser J., von Gersdorff G., Loos M., Oh J., Asanuma K., Giardino L., Rastaldi M.P., Calvaresi N., Watanabe H., Schwarz K., et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J. Clin. Invest. 113 (2004) 1390-1397
38. Riley J.L., Mao M., Kobayashi S., Biery M., Burchard J., Cavet G., Gregson B.P., June C.H., and Linsley P.S. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl. Acad. Sci. USA 99 (2002) 11790-11795
39. Roden L.D., and Myszka D.G. Global analysis of a macromolecular interaction measured on BIAcore. Biochem. Biophys. Res. Commun. 225 (1996) 1073-1077
40. + T cell activation and cytolysis. Eur. J. Immunol. 33 (2003) 3117-3126
41. Sali A., and Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234 (1993) 779-815
42. Schwartz J.C., Zhang X., Fedorov A.A., Nathenson S.G., and Almo S.C. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 410 (2001) 604-608
43. Schweitzer A.N., and Sharpe A.H. Mutual regulation between B7-1 (CD80) expressed on T cells and IL-4. J. Immunol. 163 (1999) 4819-4825
44. + T cells independent of the PD-1 receptor. J. Exp. Med. 198 (2003) 31-38
45. Stamper C.C., Zhang Y., Tobin J.F., Erbe D.V., Ikemizu S., Davis S.J., Stahl M.L., Seehra J., Somers W.S., and Mosyak L. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 410 (2001) 608-611
46. Taylor P.A., Lees C.J., Fournier S., Allison J.P., Sharpe A.H., and Blazar B.R. B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions. J. Immunol. 172 (2004) 34-39
47. + T cells leads to reversible immune dysfunction. Nat. Med. 12 (2006) 1198-1202
48. Tseng S.Y., Otsuji M., Gorski K., Huang X., Slansky J.E., Pai S.I., Shalabi A., Shin T., Pardoll D.M., and Tsuchiya H. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193 (2001) 839-846
49. Tsushima F., Iwai H., Otsuki N., Abe M., Hirose S., Yamazaki T., Akiba H., Yagita H., Takahashi Y., Omura K., et al. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur. J. Immunol. 33 (2003) 2773-2782
50. Urbani S., Amadei B., Tola D., Massari M., Schivazappa S., Missale G., and Ferrari C. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. 80 (2006) 11398-11403
51. van der Merwe P.A., Bodian D.L., Daenke S., Linsley P., and Davis S.J. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185 (1997) 393-403
52. Wang S., Bajorath J., Flies D.B., Dong H., Honjo T., and Chen L. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med. 197 (2003) 1083-1091
53. Youngnak P., Kozono Y., Kozono H., Iwai H., Otsuki N., Jin H., Omura K., Yagita H., Pardoll D.M., Chen L., and Azuma M. Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochem. Biophys. Res. Commun. 307 (2003) 672-677